ESTELLE DOS-REIS: Open Payments
NPI 1528555331 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 22 payments from 9 companies in 2025. Trend: 2023 $781 · 2024 $1,274 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $291 |
| Vanda Pharmaceuticals Inc. | 5 | $110 |
| Novo Nordisk Inc | 3 | $62 |
| ViiV Healthcare Company | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Gilead Sciences, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: ZEPBOUND, FANAPT, Ozempic, DOVATO, MOUNJARO, CAPLYTA, Rybelsus, VOQUEZNA.
Industry payments across MI — which companies pay providers there.
